Riboxin or Asparkam, which is more effective

To say which of the drugs is better and more effective is impossible. They are different both in action and in application points.

The first medication is necessary to stabilize metabolic processes, the second – to eliminate electrolyte imbalance (bringing the level of K and Mg in the blood to normal levels).

With myocardial dysfunction caused by mineral depletion, Asparkam will be more effective. To prevent a second stroke, doctors recommend drinking Riboxin.

A patient suffering from essential hypertension will be prescribed potassium-magnesium pharmaceutical preparation. Very often, doctors practice the combined use of drugs that are perfectly combined with each other.

In order to maximize the effect of treatment, you must entrust the selection of medicines to your doctor.

Depending on the nature and severity of the disease, as well as taking into account the individual characteristics of the body, the specialist will decide which tool is best used in a particular situation.

The heart is the most important human organ, the “motor” of the whole organism. It works non-stop and rest throughout life.

Every day, the heart does a tremendous job, pumping thousands of liters of blood through the vessels to supply oxygen to all tissues and organs.

The healthy state of the human body directly depends on the proper functioning of the heart and vascular system.

Cardiologists often recommend special medications to maintain the effective functioning of the cardiovascular system. These include Riboxin and Asparkam.

“Riboxin”: a description of the drug

Riboxin is a well-known metabolic drug. It normalizes metabolic processes in the myocardium, reduces oxygen deficiency of tissues. It has an antiarrhythmic effect. It also has a beneficial effect on the functioning of the liver and kidneys.


The medication has a therapeutic effect at the cellular level. By accelerating the processes of metabolism in the heart muscle, it contributes to the speedy regeneration of damaged tissues, increases the strength of heart contractions, and helps adequate relaxation of the myocardium in diastole.

Improves blood circulation in the coronary and peripheral vessels. Accelerates microcirculation of lymph and blood. Due to this, the focus of necrosis in the myocardium with a heart attack decreases.

Actively involved in energy cellular metabolism. Accelerating the utilization of glucose contributes to the normalization of the passage of biochemical processes in the body.

Helps to improve metabolic processes in conditions of hypoxia of individual organs or tissues.

The main active ingredient of the drug is inosine.

Available in three forms:

  1. Capsules (0.2 g of inosine per 1 capsule).
  2. Coated tablets (200 mg of the main component per 1 tablet).
  3. Ampules with a 2% solution for injection.

A medical device is being produced in Russia and the Republic of Belarus.

Indications and contraindications

Appointed in the following conditions:

  • Angina pectoris.
  • Arrhythmia caused by cardiac glycosides.
  • Cardiomyopathy
  • Heart disease (congenital and acquired).
  • Post-infarction period.
  • Myocarditis provoked by severe physical exertion.
  • Ischemic heart disease.
  • Fatty hepatosis (of alcoholic or medicinal origin).
  • Cirrhosis of the liver.
  • Porphyria of the liver.
  • Prevention of leukopenia after irradiation.
  • Gastric ulcer and 12 duodenal ulcer.

For this medication (in solid form), a course reception is provided. Its duration and dosage of the drug is determined by the attending physician.

Administration to patients with hypersensitivity to inosine, suffering from gout, fructose intolerance, hyperuricemia is contraindicated. Not prescribed for children under 18 years of age.

With caution, it is necessary to use the drug in patients with renal failure and diabetes.

The instruction prohibits the use of “Riboxin” by pregnant and lactating women due to the lack of data on the safety of its use.

However, the drug may be prescribed to a woman expecting a baby if fetal hypoxia is established. At the time of treatment, the patient is carefully monitored.

The medication is characterized by a minimum of side effects. Allergies are possible (urticaria, skin itching). With prolonged treatment, exacerbation of gout is occasionally observed.

“Asparkam”: description of the drug

“Asparkam” is a medicine from the group of potassium-magnesium preparations. It is a source of such essential substances as magnesium (Mg) and potassium (K).


The drug is intended to eliminate the deficiency of potassium and magnesium in the body. In addition, his task is to restore electrolyte balance and normalize metabolic processes.

The medication optimizes energy metabolism in the heart tissues, makes them more resistant to hypoxia.

Antiarrhythmic action, which is one of the advantages of the drug, allows you to stabilize the heart rhythm, improve the conductivity of impulses, and restore the function of the organ.

In addition, the drug improves the production of fats, amino acids, nucleotides for DNA.

The main components of the drug are magnesium asparaginate, potassium asparaginate.

The medication has two forms of release:

  1. Tablets (175 mg of each component in 1 pc.)
  2. Ampoules with infusion solution (volume 5 ml or 10 ml).

It is made in the Republic of Belarus, Russia, Ukraine.

Indications and contraindications

A medication is prescribed as part of complex therapy in such conditions:

  • Arrhythmias of various etiologies.
  • Digital intoxication.
  • Recovery period after a heart attack.
  • Ischemic heart disease.
  • Heart failure.

As an independent drug, it is indicated for hypomagnesemia and hypokalemia of any etiology.

Contraindications for admission are:

  • Cardiogenic shock (systolic pressure below 90 mm RT / Art.).
  • Severe myasthenia gravis.
  • Metabolic acidosis.
  • Hyperkalemia
  • Renal failure.
  • Allergy to components.
  • Dehydration.
  • Hypermagnesemia.
  • AV – blockade of the II-III degree.

Women who are expecting a baby, or who are at the stage of lactation, may prescribe medication according to indications. With extreme caution, they are prescribed in the first trimester.

After a year, babies and babies are prescribed a pharmaceutical preparation only in case of emergency, in cases of potassium deficiency identified as a result of laboratory tests.

For the treatment of children, tablets are used. The dosage is carefully selected by a specialist.

Intravenously, babies are not given injections, only in case of a direct threat to life.

Side effects are rare. Nausea, diarrhea, flatulence, epigastric pain, vomiting, a drop in blood pressure, fatigue, impaired myocardial conduction, muscle weakness, and allergic reactions may appear.

What are the similarities of drugs

The drugs have some common features.

The main similarity is the same therapeutic orientation. Medications improve the structural condition and functionality of the heart muscle.

Also unifying moments are:

  • A variety of forms of release of both of these drugs.
  • The same duration of the course of admission (one month).
  • Good compatibility with other therapeutic agents.
  • A similar list of indications for use.
  • Rare occurrence of adverse reactions.

Available in pharmacies without a prescription. They have almost the same cost. Asparkam tablets – 43-70 rubles, ampoules – 96-110 rubles. Riboxin tablets – 53-86 rubles, ampoules – 66-80 rubles.

What are the differences

Medicines differ in the following parameters:

  1. They belong to different pharmacological groups.
  2. They have a different mechanism of action.
  3. They differ in chemical composition.
  4. Riboxin has a wider list of indications.
  5. Asparkam has a longer list of adverse reactions and contraindications.
  6. “Riboxin” can not be prescribed to children.

Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *